These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Kitano A; Norikura T; Matsui-Yuasa I; Shimakawa H; Kamezawa M; Kojima-Yuasa A J Med Food; 2022 Oct; 25(10):982-992. PubMed ID: 36201260 [TBL] [Abstract][Full Text] [Related]
24. Probiotics-Based Treatment as an Integral Approach for Alcohol Use Disorder in Alcoholic Liver Disease. Fuenzalida C; Dufeu MS; Poniachik J; Roblero JP; Valenzuela-Pérez L; Beltrán CJ Front Pharmacol; 2021; 12():729950. PubMed ID: 34630107 [TBL] [Abstract][Full Text] [Related]
25. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice. Ferrere G; Wrzosek L; Cailleux F; Turpin W; Puchois V; Spatz M; Ciocan D; Rainteau D; Humbert L; Hugot C; Gaudin F; Noordine ML; Robert V; Berrebi D; Thomas M; Naveau S; Perlemuter G; Cassard AM J Hepatol; 2017 Apr; 66(4):806-815. PubMed ID: 27890791 [TBL] [Abstract][Full Text] [Related]
26. Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968-1998)--a review. Lieber CS Alcohol Clin Exp Res; 1999 Jun; 23(6):991-1007. PubMed ID: 10397283 [TBL] [Abstract][Full Text] [Related]
27. High producer variant of lipoprotein lipase may protect from hepatocellular carcinoma in alcohol-associated cirrhosis. Schmalz F; Fischer J; Innes H; Buch S; Möller C; Matz-Soja M; von Schönfels W; Krämer B; Langhans B; Klüners A; Soyka M; Stickel F; Nattermann J; Strassburg CP; Berg T; Lutz P; Nischalke HD JHEP Rep; 2023 Apr; 5(4):100684. PubMed ID: 36879887 [TBL] [Abstract][Full Text] [Related]
28. Excessive bile acid activated NF-kappa B and promoted the development of alcoholic steatohepatitis in farnesoid X receptor deficient mice. Wu WB; Chen YY; Zhu B; Peng XM; Zhang SW; Zhou ML Biochimie; 2015 Aug; 115():86-92. PubMed ID: 26025474 [TBL] [Abstract][Full Text] [Related]
31. Hydroxytyrosol attenuates ethanol-induced liver injury by ameliorating steatosis, oxidative stress and hepatic inflammation by interfering STAT3/iNOS pathway. Fang X; Cao J; Tao Z; Yang Z; Dai Y; Zhao L Redox Rep; 2023 Dec; 28(1):2187564. PubMed ID: 36932927 [No Abstract] [Full Text] [Related]
32. Alcohol or Gut Microbiota: Who Is the Guilty? Meroni M; Longo M; Dongiovanni P Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540133 [TBL] [Abstract][Full Text] [Related]
33. Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis. Nagata K; Suzuki H; Sakaguchi S J Toxicol Sci; 2007 Dec; 32(5):453-68. PubMed ID: 18198478 [TBL] [Abstract][Full Text] [Related]
34. Key Signaling in Alcohol-Associated Liver Disease: The Role of Bile Acids. Way GW; Jackson KG; Muscu SR; Zhou H Cells; 2022 Apr; 11(8):. PubMed ID: 35456053 [TBL] [Abstract][Full Text] [Related]
35. Adult mouse model of early hepatocellular carcinoma promoted by alcoholic liver disease. Ambade A; Satishchandran A; Gyongyosi B; Lowe P; Szabo G World J Gastroenterol; 2016 Apr; 22(16):4091-108. PubMed ID: 27122661 [TBL] [Abstract][Full Text] [Related]
36. [Alcoholic liver diseases in Japan and modification by hepatitis virus]. Horie Y; Yamagishi Y; Ishii H Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Oct; 38(5):403-14. PubMed ID: 14639919 [TBL] [Abstract][Full Text] [Related]
37. [Alcoholic liver disease]. Waluga M; Hartleb M Wiad Lek; 2003; 56(1-2):61-70. PubMed ID: 12901271 [TBL] [Abstract][Full Text] [Related]
38. [National survey of alcoholic liver disease in Japan]. Horie Y; Ishii H; Hibi T Nihon Arukoru Yakubutsu Igakkai Zasshi; 2004 Dec; 39(6):505-10. PubMed ID: 15675363 [TBL] [Abstract][Full Text] [Related]
39. Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease. Wu W; Zhu B; Peng X; Zhou M; Jia D; Gu J Biochem Biophys Res Commun; 2014 Jan; 443(1):68-73. PubMed ID: 24269813 [TBL] [Abstract][Full Text] [Related]